Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …

Background Early detection of response to treatment is critically important in gastrointestinal
stromal tumors (GIST). Therefore, the present systematic review and meta‐analysis …

Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose of …

Purpose: Controversies remain over the actual risk of developing a second primary
malignancy (SPM) as a consequence of I-131 treatment in patients with differentiated thyroid …

Objectives Salivary gland impairment after high-dose radioiodine (131 I) treatment is well
recognized. The aim of this study was to determine the protective effect of vitamin E on radiation…

Objective (s): In view of somatostatin receptor (SSR) expression on cell membranes of the
majority of neuroendocrine tumors (NETs), functional imaging exploiting analogs of SSR …

Objectives The aim of this study was to investigate and validate the performance of individual
and ensemble machine learning models (EMLMs) based on magnetic resonance imaging (…

Background 99m Tc–prostate-specific membrane antigen (PSMA) SPECT/CT is less expensive
and readily available modality compared with 68 Ga-PSMA PET/CT for imaging prostate …

Neuroendocrine tumors (NETs) are rare in childhood. Neuroblastoma is the most common
pediatric extracranial solid tumor, occurring> 90% in children younger than 5 years of age. …

Purpose: There are a limited number of case reports confirming the radioiodine (I-131)
presence in tears and only a few case reports of lacrimal gland dysfunction after I-131 therapy. …